Business Strategy News 8 November 2025

Zoom Communications (ZM) Stock Today, November 23, 2025: AI Pivot Faces a Big Earnings Test

Updated: November 23, 2025 Key Takeaways Note: This article is for information and analysis only and is not investment advice. 1. Zoom stock today: price and valuation snapshot As of the close on Friday, November 21, 2025, Zoom Communications (still

23 November 2025

Artificial Intelligence·Business Strategy·Earnings·Stock Market·Technology

UAMY Stock Skyrockets on $245M Pentagon Deal – Bubble or Buy?

UAMY Stock Today (Nov 19, 2025): United States Antimony Slides as Management Highlights Strategy at Southwest IDEAS Conference

Nov 19, 2025 — Shares of United States Antimony Corporation (NYSE American: UAMY) traded lower on Wednesday while management presented at the 17th Annual Southwest IDEAS Conference and reiterated key growth initiatives tied to U.S. critical‑minerals policy and new commercial

20 November 2025

Business Strategy·Company News·Investment Analysis·Stock Market

Nokia Oyj (NOK) Reboots for the AI Supercycle: New Strategy, 2028 Profit Target and Deep Restructuring Shake Markets

On 19 November 2025, Nokia Oyj used its long-awaited Capital Markets Day in New York to unveil a sweeping AI‑centric strategy, a new 2028 profit target and a major overhaul of its operating model — and investors immediately weighed in.

19 November 2025

Artificial Intelligence·Business Strategy·Stock Market·Technology·Telecommunications

Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Published November 19, 2025 Target (NYSE: TGT) is heading into the critical holiday shopping season under intense pressure after reporting another quarter of declining sales, trimming its profit outlook and unveiling an ambitious turnaround plan built around price cuts, store

19 November 2025

Artificial Intelligence·Business Strategy·Retail News·Stock Market

Apple CEO Succession 2026: Tim Cook’s Possible Exit, John Ternus’ Rise – and How Much Money Is on the Line

Published: November 17, 2025 Apple is quietly edging toward the most consequential leadership change since Steve Jobs handed the reins to Tim Cook in 2011. Over the past three days, a wave of reports citing the Financial Times and The

17 November 2025

Apple Inc·Business Strategy·Company News·Tech Industry

Amaze Holdings (AMZE) Completes The Food Channel Acquisition; Plans Platform Revamp for Culinary Creators — Nov 12, 2025

Amaze Holdings (AMZE) Soars on Q3 2025 Earnings as Revenue Jumps 1,884% and Creator-Commerce Strategy Accelerates

Published: November 14, 2025 Amaze Holdings, Inc. (NYSE American: AMZE) lit up the micro-cap tech screens on Friday after reporting third-quarter 2025 results showing a 1,884% year‑over‑year revenue surge and outlining an aggressive path to profitability built around AI‑powered creator

14 November 2025

Business Strategy·Earnings Reports·Financial News·Growth Stocks

Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific Inc. (NYSE American: MLSS) is back on traders’ radar today after a sharp after‑hours spike, strong pre‑market performance and fresh Q3 2025 numbers that show progress on costs but lingering listing‑compliance and funding risks. Key headlines on Milestone

14 November 2025

Business Strategy·Company Updates·Earnings Reports·Financial Results·Stock Market News

Merck to Buy Cidara Therapeutics for $9.2 Billion in Bold Bet on Long‑Acting Flu Prevention

Merck & Co. (NYSE: MRK) has agreed to acquire Cidara Therapeutics (Nasdaq: CDTX) in a deal valued at about $9.2 billion, a blockbuster move that gives the pharma giant a late‑stage, long‑acting influenza prevention drug as it prepares for life

14 November 2025

Business Strategy·Healthcare Innovation·Mergers & Acquisitions·Pharma News

Paysafe (PSFE) Tumbles After Q3 2025 Earnings Miss, Guidance Cut and New Endava AI Partnership

London / New York – November 13, 2025 — Paysafe Limited (NYSE: PSFE) is in the spotlight today after releasing its third‑quarter 2025 results, slashing its full‑year outlook and unveiling a new multi‑year AI‑driven payments partnership with Endava. The mixed

13 November 2025

Business Strategy·Earnings Reports·Market Trends

Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic Poised to Beat OpenAI to Profitability as It Diversifies Beyond Nvidia — What’s New Today (Nov. 12, 2025)

Key Points at a Glance What the New Profitability Forecasts Tell Us Internal projections shared with investors show starkly different roads to the black for the two most closely watched AI startups. Anthropic outlines a path to break‑even in 2028,

12 November 2025

Artificial Intelligence·Business Strategy·Company News·Market Trends·Tech Industry

Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Marriott Ends Sonder Partnership After ‘Default,’ Cuts 2025 Net Rooms Growth Outlook to ~4.5% — What Travelers & Investors Need to Know (Nov 10, 2025)

Published: November 10, 2025 Summary: Marriott International has terminated its licensing agreement with short‑term‑rental operator Sonder after a “default,” removed Sonder listings from Marriott Bonvoy channels, and trimmed its 2025 net rooms growth outlook to ~4.5%. Here’s the latest on

10 November 2025

Business Strategy·Travel News

Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Pfizer Clinches $10B Takeover of Metsera as Novo Nordisk Bows Out — Full Terms, Timeline, and What It Means (Nov. 8, 2025)

Metsera (NASDAQ: MTSR) and Pfizer struck an amended deal worth up to $10B after Novo Nordisk exited the bidding. Here are the final terms, key dates, and what investors should watch next. Updated: November 8, 2025 Top takeaways What changed

8 November 2025

Business Strategy·Industry Analysis·Mergers & Acquisitions·Pharma News

Business Strategy News 8 November 2025 - 23 November 2025